Fact CheckerSign in

NCT05443633Recruiting

Enhancing Language Function in Aphasia

Enhancing Language Function in Aphasia Using Behavioral Language Intervention

Source: ClinicalTrials.gov · Last updated 9 Dec 2024 · Not updated for over 12 months - ask the site whether it is still open

Brief summary (registry, in English)

Aphasia is an acquired impairment of language, that commonly results from damage to language areas in the brain (typically the left side of the brain). This impairment is seen in many aspects of language, including understanding, speaking, reading and writing. It is estimated that about 2 million individuals are currently living with aphasia in the United States. Further, about 200,000 Americans acquire aphasia every year (National Aphasia Association, 2020). Aphasia poses significant impact on the affected individuals and their families. Behavioral treatments that target language deficits have been shown to enhance overall communication skills and life satisfaction among individuals with aphasia. Although there is evidence that suggests that treatment is efficacious for individuals with aphasia, the extent of improvement long-term coupled with the neural patterns among those individuals are largely unknown. The current study aims to investigate the efficacy of language-based treatment and its corresponding neural patterns.

Status (registry)
Recruiting
Study type
Interventional
Enrollment
30 (estimated)
First submitted
29 Jun 2022
Start date
30 Oct 2022
Primary completion date
30 Jun 2027
Lead sponsor
University of Arizona
NCT number
NCT05443633

What you commit to

  • Study type: Interventional
  • Planned participants: 30
  • From 30 Oct 2022 to the primary completion date, 30 Jun 2027
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Individuals with highly magnetizable metallic implants, including certain dental work, may be excluded due to image quality in MRI.
  • Individuals who have had a brain surgery in the past
  • Individuals with implanted metallic skull plates or intracranial implants
  • Individuals with severe non-linguistic cognitive disturbances impeding language therapy

Other illness

  • Individuals diagnosed with mood, anxiety, psychotic or substance abuse disorders.
  • Individuals with other neurological disorders besides the ones of interest for the study (e.g., epilepsy, Multiple Sclerosis, Parkinson's Disease)
  • Individuals with contraindications for MRI. This includes but is not limited to pacemakers, metallic cardiac pumps, valves, magnetic materials such as surgical clips, implanted electronic perfusion pumps, or any other condition that would preclude proximity to a strong magnetic field.
  • Severe systemic disease (e.g., renal failure)
  • Individuals with a history of epileptic activity in the past 12 months
  • Individuals with a personal or family history of epilepsy or other seizure disorders will not be included in the study.
  • Individuals who have a history of excessive use of alcohol or drugs
  • Individuals with premorbid psychiatric disease affecting communication

Other

  • Individuals suffering from clinically significant claustrophobia
  • Poor overall health
  • Individuals who are pregnant
  • Individuals with skin lesions or skull damage

Who the study is looking for

  • Present with speech-language impairment (aphasia) caused by stroke or dementia
  • A medical diagnosis of primary progressive aphasia (PPA) by a neurologist or physician
  • Are native speakers of English
  • Present with no contraindications for MRI
  • Have adequate (normal or corrected to normal) vision and hearing

Age in the registry: 21 years to 80 years · Sex: All · Accepts healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
University of Arizona
Coordinator of this site? Confirm its status
TucsonUnited StatesRecruiting

This page is information, not medical advice. Discuss any trial with your doctor.